Exendin 9-39
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Exendin 9-39, covering 2013-01-23 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia [Phase 1]